Results 1 to 10 of about 5,332,530 (372)
Colorectal cancer statistics, 2023
Ca, 2023 Colorectal cancer (CRC) is the second most common cause of cancer death in the United States. Every 3 years, the American Cancer Society provides an update of CRC statistics based on incidence from population‐based cancer registries and mortality from ...
R. Siegel +4 more
semanticscholar +1 more source
Colorectal cancer statistics, 2020
Ca, 2020 Colorectal cancer (CRC) is the second most common cause of cancer death in the United States. Every 3 years, the American Cancer Society provides an update of CRC occurrence based on incidence data (available through 2016) from population‐based cancer ...
R. Siegel +8 more
semanticscholar +1 more source
Ca, 2021 This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer.
H. Sung +6 more
semanticscholar +1 more source
Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death.
New England Journal of Medicine, 2022 BACKGROUND Although colonoscopy is widely used as a screening test to detect colorectal cancer, its effect on the risks of colorectal cancer and related death is unclear.
M. Bretthauer +20 more
semanticscholar +1 more source
Wnt signaling in colorectal cancer: pathogenic role and therapeutic target
Molecular Cancer, 2022 Background The Wnt signaling pathway is a complex network of protein interactions that functions most commonly in embryonic development and cancer, but is also involved in normal physiological processes in adults.
Hui-Ying Zhao +7 more
semanticscholar +1 more source
Global patterns and trends in colorectal cancer incidence and mortality
Gut, 2016 Objective The global burden of colorectal cancer (CRC) is expected to increase by 60% to more than 2.2 million new cases and 1.1 million deaths by 2030. In this study, we aim to describe the recent CRC incidence and mortality patterns and trends linking ...
M. Arnold +5 more
semanticscholar +1 more source
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
New England Journal of Medicine, 2020 BACKGROUND Programmed death 1 (PD-1) blockade has clinical benefit in microsatellite-instability-high (MSI-H) or mismatch-repair-deficient (dMMR) tumors after previous therapy.
T. André +20 more
semanticscholar +1 more source
Cancers, 2021 Simple Summary According to the available data, colorectal cancer (CRC) is one of the most common malignant neoplasms. Depending on the location, type of cancer or gender, it is ranked 2nd to 4th in terms of incidence in the world.
T. Sawicki +5 more
semanticscholar +1 more source
The Consensus Molecular Subtypes of Colorectal Cancer
Nature Network Boston, 2015 Colorectal cancer (CRC) is a frequently lethal disease with heterogeneous outcomes and drug responses. To resolve inconsistencies among the reported gene expression–based CRC classifications and facilitate clinical translation, we formed an international
J. Guinney +39 more
semanticscholar +1 more source
Colorectal cancer statistics, 2017
Ca, 2017 Colorectal cancer (CRC) is one of the most common malignancies in the United States. Every 3 years, the American Cancer Society provides an update of CRC incidence, survival, and mortality rates and trends.
R. Siegel +6 more
semanticscholar +1 more source